No protocol objective.
This is a protocol.
Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis
You may also be interested in:
- Antibiotics for brain abscesses in people with cyanotic congenital heart disease
- Levosimendan to prevent reduced heart function and death after heart surgery in infants and children with congenital heart disease
- Milrinone to prevent reduced heart function and death after heart surgery in children
- Beta-blocker treatment in Marfan syndrome
- What are the benefits and risks of corticosteroids for preventing inflammation in children who undergo heart surgery involving a heart-lung machine?